Latest filing published 06 Mar 2009 for WATSON PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Mark Durand: trading record in brief
Mark Durand discloses dealings in Watson Pharmaceuticals Inc to SEC (Form 4). In total, 3 filings cover trades dated from 26 November 2007 to 5 March 2009.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 March 2009, the filings show a share grant in Watson Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Durand
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,466 shares0Common Stock, par value $0.0033SEC:0001179110-09-004469:0
- 8,500 shares0Common Stock, par value $0.0033SEC:0001179110-08-005918:0
- 10,000 shares0Common Stock, par value $0.0033SEC:0001179110-07-022229:0
3 of 3 declarations
